AdSS Antibodies

Santa Cruz Biotechnology delivers a wide array of AdSS monoclonal antibodies for studying adenosine deaminase (ADA) enzyme. AdSS monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Adenosine deaminase plays a crucial role in purine metabolism, converting adenosine to inosine, which is essential for maintaining cellular homeostasis and regulating immune responses. Dysregulation of adenosine deaminase has been implicated in several diseases, including severe combined immunodeficiency and various cancers, making it a significant target in biomedical research. AdSS monoclonal antibodies enable researchers to investigate adenosine deaminase expression, localization, and interactions in cellular pathways. Understanding adenosine deaminase function and regulation can lead to breakthroughs in therapeutic development for related disorders. Researchers worldwide rely on AdSS monoclonal antibodies to advance scientific knowledge and explore potential treatments. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in uncovering new insights about adenosine deaminase and its role in human health and disease.